Literature DB >> 14729792

Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial infarction.

N Ikeda1, T Yasu, N Kubo, S Hashimoto, Y Tsuruya, M Fujii, M Kawakami, M Saito.   

Abstract

OBJECTIVE: To compare the effects of nicorandil (a hybrid ATP sensitive potassium channel (K+(ATP) channel) opener/nitric oxide donor) with those of isosorbide dinitrate (ISDN) on myocardial microcirculation and cardiac function in patients with acute myocardial infarction (AMI) who had undergone reperfusion treatment by direct balloon angioplasty.
DESIGN: Double blind randomised study. PATIENTS: 60 patients with AMI in Killip class I.
INTERVENTIONS: Patients were assigned into two treatment groups: a nicorandil group (n = 30) and an ISDN group (n = 30). Each drug was infused intravenously at 6 mg/h for 72 hours starting at admission and was administered directly to the treated coronary artery immediately after angioplasty.
RESULTS: Compared with ISDN, nicorandil more frequently caused recovery of ST segment elevation just after reperfusion (15 of 27 (55.5%) in the nicorandil group v 5 of 26 (19.2%) in the ISDN group, p = 0.006). The nicorandil group had higher values of averaged peak velocity 40 minutes after reperfusion (mean (SD) 24.8 (13.3) cm/s v 16.0 (11.1) cm/s, p = 0.045) and higher values of regional wall motion of the infarcted area three weeks after onset of AMI (-1.78 (1.11) v -2.50 (1.04) SD/chord, p = 0.046).
CONCLUSIONS: A combination of nicorandil drip infusion starting before reperfusion and intracoronary injection immediately after reperfusion is more effective than a similarly performed infusion of ISDN in preserving myocardial microcirculation in the reperfused AMI area. The nicorandil regimen resulted in better left ventricular regional wall motion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729792      PMCID: PMC1768080          DOI: 10.1136/hrt.2003.013789

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  36 in total

1.  Nicorandil and leukocyte activation.

Authors:  Takanori Yasu; Nahoko Ikeda; Nobuhiko Ishizuka; Eiji Matsuda; Masanobu Kawakami; Masatoshi Kuroki; Nobuo Imai; Hiroto Ueba; Shunichi Fukuda; Geert W Schmid-Schönbein; Muneyasu Saito
Journal:  J Cardiovasc Pharmacol       Date:  2002-11       Impact factor: 3.105

2.  Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty.

Authors:  M A Leesar; M F Stoddard; B Dawn; V G Jasti; R Masden; R Bolli
Journal:  Circulation       Date:  2001-06-19       Impact factor: 29.690

3.  Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1.

Authors:  Takashi Miki; Masashi Suzuki; Tadao Shibasaki; Hiroko Uemura; Toshiaki Sato; Kaori Yamaguchi; Haruhiko Koseki; Toshihiko Iwanaga; Haruaki Nakaya; Susuma Seino
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

Review 4.  Cardiovascular and biological effects of K+ channel openers, a class of drugs with vasorelaxant and cardioprotective properties.

Authors:  C Richer; J Pratz; P Mulder; S Mondot; J F Giudicelli; I Cavero
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

5.  Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial.

Authors: 
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

6.  Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels.

Authors:  William A Chutkow; Jielin Pu; Matthew T Wheeler; Tomoyuki Wada; Jonathan C Makielski; Charles F Burant; Elizabeth M McNally
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

7.  Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog.

Authors:  J L Romson; B G Hook; S L Kunkel; G D Abrams; M A Schork; B R Lucchesi
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

8.  Postischemic recovery in the stunned myocardium after reperfusion in the presence or absence of a flow-limiting coronary artery stenosis.

Authors:  N E Farber; G M Pieper; G J Gross
Journal:  Am Heart J       Date:  1988-08       Impact factor: 4.749

9.  Assessment of the antiarrhythmic activity of nicorandil during myocardial ischemia and reperfusion.

Authors:  R D Kempsford; B J Hawgood
Journal:  Eur J Pharmacol       Date:  1989-04-12       Impact factor: 4.432

Review 10.  Effects of nicorandil on coronary circulation and myocardial ischemia.

Authors:  G Gross; G Pieper; N E Farber; D Warltier; H Hardman
Journal:  Am J Cardiol       Date:  1989-06-20       Impact factor: 2.778

View more
  11 in total

1.  Optimal therapeutic strategies in the setting of post-infarct no reflow: the need for a pathogenetic classification.

Authors:  L Galiuto
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

Review 2.  Management of microvascular dysfunction and reperfusion injury.

Authors:  A Prasad; B J Gersh
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

3.  Effects of nicorandil on cardiac sympathetic nerve activity after reperfusion therapy in patients with first anterior acute myocardial infarction.

Authors:  Shu Kasama; Takuji Toyama; Hisao Kumakura; Yoshiaki Takayama; Shuichi Ichikawa; Tadashi Suzuki; Masahiko Kurabayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-10-02       Impact factor: 9.236

4.  The effect of nicorandil in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a systematic review and meta-analysis.

Authors:  Zhenjun Ji; Rui Zhang; Wenbin Lu; Genshan Ma; Yangyang Qu
Journal:  Ir J Med Sci       Date:  2019-05-30       Impact factor: 1.568

5.  Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: A randomized factorial trial.

Authors:  Chunhong Chen; Xianghua Fu; Wei Li; Xinwei Jia; Shiru Bai; Wei Geng; Kun Xing
Journal:  Exp Ther Med       Date:  2015-07-07       Impact factor: 2.447

Review 6.  Nicorandil: a review of its use in the management of stable angina pectoris, including high-risk patients.

Authors:  Dene Simpson; Keri Wellington
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  Reperfusion injury as a therapeutic challenge in patients with acute myocardial infarction.

Authors:  Antonio Rodríguez-Sinovas; Yaser Abdallah; Hans Michael Piper; David Garcia-Dorado
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

8.  Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention.

Authors:  Zhihua Pang; Wei Zhao; Zhuhua Yao
Journal:  Med Sci Monit       Date:  2017-06-15

9.  Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention.

Authors:  Jing Yang; Jidong Zhang; Wei Cui; Fan Liu; Ruiqin Xie; Xiaohong Yang; Guoqiang Gu; Hongmei Zheng; Jingchao Lu; Xiuchun Yang; Guangming Zhang; Qian Wang; Xue Geng
Journal:  Anatol J Cardiol       Date:  2014-04-16       Impact factor: 1.596

Review 10.  Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.

Authors:  Li Xu; Lefeng Wang; Kuibao Li; Zhiyong Zhang; Hao Sun; Xinchun Yang
Journal:  Drug Des Devel Ther       Date:  2019-04-29       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.